Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
Conditions: Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Interventions: Drug: Imatinib; Drug: Ponatinib; Drug: Blinatumomab; Other: Indication for stem cell transplantation Sponsors: Goethe University; Deutsche Leuk ämie-& Lymphom-Hilfe; German Federal Ministry of Education and Research Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Chemotherapy | Education | Germany Health | Gleevec | Leukemia | Research | Stem Cell Therapy | Stem Cells | Transplants | Universities & Medical Training